About this Research Topic
This Research Topic receives both basic and applied types of research about health-promoting bacteria (such as lactic acid bacteria, bifidobacteria, and Akkermansia muciniphila among others) in the treatment and prevention of i. bacterial such as Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecalis (VREF), Clostridium difficile, Helicobacter pylori, Mycobacterium tuberculosis, Neisseria gonorrhoeae, etc., ii. viral such as HIV, SARS-CoV-2, influenza, norovirus, rotavirus, etc., and iii. fungal such as Candida spp, Cryptococcus spp, etc. infections. We welcome the submission of Original Research, Methods, Perspective, Review, or Mini-Review that cover, but not limited to, the following topics:
- Isolation, identification, and characterization of novel probiotic candidates with antimicrobial properties;
- Molecular mechanisms of health-promoting bacteria in combating pathogens, including multi-drug resistant bacteria;
- Cross-talk of probiotics and/or probiotic candidates with the host and host-microbiota;
- Probiotic bacteria delivering therapeutics against bacterial and virus pathogens include antigens, antibodies, and other antimicrobials;
- New technologies to advance the mechanistic understanding and bioengineering of health-promoting bacteria.
Keywords: probiotics, pathogens, antimicrobials, antibiotic resistance, live biotherapeutics
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.